Back
EDAP TMS SA Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison
Buy
60
EDAP
EDAP TMS SA
Last Price:
$3.69
Seasonality Move:
28.73%
Sell
34
CRNX
Crinetics Pharmaceuticals, Inc.
Last Price:
$53.24
Seasonality Move:
-11.9%
Buy
60
EDAP TMS SA (EDAP)
is a Buy
Is EDAP TMS SA a Buy, Sell or Hold?
-
The current EDAP TMS SA [EDAP] share price is $3.68. The Score for EDAP is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
EDAP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Crinetics Pharmaceuticals, Inc. (CRNX)
is a Sell
Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.25. The Score for CRNX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EDAP Stock Price Chart
What is EDAP TMS SA's stock price today?
-
The EDAP TMS SA share price today is $3.68Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EDAP is experiencing slight selling pressure.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals, Inc.'s stock price today?
-
The Crinetics Pharmaceuticals, Inc. share price today is $53.25Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing selling pressure, which indicates risk of future bearish movement.
EDAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.35 | Buy |
| Relative Strength Index (14 RSI): | 67.81 | Buy |
| Chaikin Money Flow: | -12899 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.45 - 3.47) | Buy |
| Bollinger Bands (100): | (1.87 - 2.91) | Buy |
CRNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.51 | Buy |
| Relative Strength Index (14 RSI): | 65.7 | Buy |
| Chaikin Money Flow: | -2109383 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.45 - 50.61) | Buy |
| Bollinger Bands (100): | (35.52 - 47.68) | Buy |
EDAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.54 | Buy |
| 20-day SMA: | 3.11 | Buy |
| 50-day SMA: | 2.56 | Buy |
| 200-day SMA: | 2.05 | Buy |
| 8-day EMA: | 3.55 | Buy |
| 20-day EMA: | 3.2 | Buy |
| 50-day EMA: | 2.77 | Buy |
| 200-day EMA: | 2.41 | Buy |
CRNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.43 | Buy |
| 20-day SMA: | 48.84 | Buy |
| 50-day SMA: | 45.85 | Buy |
| 200-day SMA: | 36.19 | Buy |
| 8-day EMA: | 50.48 | Buy |
| 20-day EMA: | 48.82 | Buy |
| 50-day EMA: | 46.16 | Buy |
| 200-day EMA: | 40.41 | Buy |
EDAP TMS SA Earnings Growth & EDAP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and an increase next year of $0.13 per share.
Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.
EDAP TMS SA Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Crinetics Pharmaceuticals, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||